How diet and medicine affect gut health in PKU children
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how a phenylalanine-restricted diet or certain PKU medicines affect gut health in children with PKU. It also includes healthy siblings or household members as a comparison group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 3 to 17 years old
- Your child was diagnosed with PKU through a newborn screen
- Your child is not on a special diet for any other medical reason (except PKU)
- Your child does not have a chronic gut, liver, or kidney disease
- Your child's PKU treatment is one of the three specific types the study is looking for
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called sepiapterin to see if it can help control blood phenylalanine levels in people with PKU. The trial aims to find a safe and effective dose for different age groups.
This trial tests an investigational drug (AG-181) for people with PKU who have a specific genetic change (R408W mutation). It aims to check if the drug is safe and how it works in your body.
This study looks at eating habits and disorders in people with phenylketonuria (PKU) who are treated at a specific hospital in Nancy, France. Participating involves sharing information, which may help doctors better understand eating challenges in PKU.
This study looks at how educational, social support, and nutrition help affect pregnancy outcomes and quality of life in women with PKU. It may help you better manage PKU-related needs before and during pregnancy.
This study is testing whether a new microtablet form of protein substitute is easy and acceptable for people with PKU to take. If you qualify, you'll take these tablets instead of your current protein substitute and share your experience with the research team.
This trial is testing a new slow-release protein substitute for people with PKU, to see if it is acceptable and well-tolerated. You would try the product for 7 days, replacing your usual substitute, to see how it fits into your routine.
Hear when a new Phenylketonuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.